Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TENET HEALTHCARE CORPORATION

(THC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Tenet Healthcare : RBC Raises Price Target on Tenet Healthcare to $78 From $66, Maintains Outperform Rating

06/10/2021 | 09:04am EDT


© MT Newswires 2021
All news about TENET HEALTHCARE CORPORATION
07/30TENET HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
07/29INSIDER TRENDS : Tenet Healthcare Sees 90 Days of Insider Buying Trend Reducing ..
MT
07/28Today on Wall Street: Better-than-expected earnings ahead of the Fed
07/28ANALYST RECOMMENDATIONS : Flutter, Hasbro, MGM Resort, Microsoft Vodafone...
07/27TENET HEALTHCARE : Seaport Global Securities Adjusts Tenet Healthcare PT to $85 ..
MT
07/27TENET HEALTHCARE : Announces Results of the 2021 Healthy Over Hungry® Cereal Dri..
BU
07/23TENET HEALTHCARE : Stephens Adjusts Tenet Healthcare PT to $78 From $72, Maintai..
MT
07/23TENET HEALTHCARE : Deutsche Bank Adjusts Tenet Healthcare PT to $80 From $69, Ma..
MT
07/23TENET HEALTHCARE : Credit Suisse Raises Tenet Healthcare's PT to $88 from $71, A..
MT
07/23TENET HEALTHCARE : RBC Boosts Price Target on Tenet Healthcare to $83 From $78, ..
MT
More news
Financials (USD)
Sales 2021 19 669 M - -
Net income 2021 605 M - -
Net Debt 2021 13 330 M - -
P/E ratio 2021 12,9x
Yield 2021 -
Capitalization 7 672 M 7 672 M -
EV / Sales 2021 1,07x
EV / Sales 2022 1,03x
Nbr of Employees 107 000
Free-Float 67,7%
Chart TENET HEALTHCARE CORPORATION
Duration : Period :
Tenet Healthcare Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TENET HEALTHCARE CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 71,84 $
Average target price 81,00 $
Spread / Average Target 12,8%
EPS Revisions
Managers and Directors
Ronald A. Rittenmeyer Executive Chairman & Chief Executive Officer
Saumya Sutaria President, Chief Operating Officer & Director
Daniel J. Cancelmi Chief Financial Officer & Executive Vice President
Paola M. Arbour Chief Information Officer & Executive VP
Howard B. Hacker Chief Compliance Officer & Executive VP